Levonorgestrel 52 mg intrauterine system (Levosert®)/Liletta®) in contraception: a profile of its use Katherine A. Lyseng-Williamson Adis Drug Q&A 05 November 2020 Pages: 539 - 546
Rimegepant orally disintegrating tablets in the acute treatment of migraine: a profile of their use Esther S. KimKatherine A. Lyseng-Williamson Adis Drug Q&A 30 October 2020 Pages: 547 - 552
Tofacitinib in ulcerative colitis: a profile of its use Young-A Heo Adis Drug Q&A 28 October 2020 Pages: 553 - 563
First reports of adverse drug reactions and interactions Drug Reactions and Interactions 10 November 2020 Pages: 564 - 564
Self-medication during Covid-19 pandemic: challenges and opportunities Muna MalikMuhammad Junaid TahirRabia Hussain Commentary 03 October 2020 Pages: 565 - 567
Severe prolonged neutropenia following administration of tocilizumab in a patient affected by COVID-19: a case report and brief review of the literature Luca BernardoStefania Del SestoPaolo Antonio Ascierto Therapy in Practice Open access 14 September 2020 Pages: 568 - 572
“Over-the-counter” cannabidiol (CBD) sold in the community pharmacy setting in Colorado Leticia A. SheaMegan LeedsAllyson Spence Original Research Article 29 September 2020 Pages: 573 - 582
Exploring the utility of a spontaneous adverse drug reaction reporting system in identifying drug–drug interactions between antiretrovirals, antitubercular drugs, and cotrimoxazole: a case/non-case analysis Josiah Tatenda MasukaAnisa MosamStar Khoza Original Research Article 22 September 2020 Pages: 583 - 589
Adherence of patients with type 2 diabetes to refills and medications: a comparison between ‘telephone and collect’ and conventional counter services in a health clinic Khalidah MaruanKhairil Anuar Md IsaMahmathi Karuppannan Original Research Article 14 September 2020 Pages: 590 - 597
Correction to: Lemborexant in insomnia disorder: a profile of its use Hannah A. Blair Correction 01 October 2020 Pages: 598 - 599
